Experience. Integrity. IMPACT.
What We Do

Holly Buchanan, M.S., RAC, Promoted to Principal Consultant

RESEARCH TRIANGLE PARK, NC: 23 September 2020 – In March 2020, Holly Buchanan, M.S., RAC, was promoted to the position of Principal Consultant at Impact Pharmaceutical Services, Inc. (IMPACT).

Holly joined IMPACT in 2017 with over 15 years of medical writing, regulatory, and program management experience within CRO and pharmaceutical environments. Holly’s experience ranges from early to late phase drug development, with her most recent experiences being on original marketing applications, as well as line extensions and responses to regulatory agency questions. Holly is an excellent reviewer who embraces our commitment to a culture of learning, serving as a mentor to many of our more junior medical writers and fostering their career development.

Continue reading

Rebecca Pogue, PhD, Promoted to Consultant

RESEARCH TRIANGLE PARK, NC: 23 September 2020 – In February 2020, Rebecca Pogue, PhD, was promoted to the position of Consultant at Impact Pharmaceutical Services, Inc. (IMPACT).

Rebecca joined IMPACT in October 2017 with over 10 years of medical writing experience within CRO and pharmaceutical environments, having worked on numerous types of early and late phase regulatory documents. Since joining IMPACT, Rebecca has continued working on an increasing breadth and complexity of documents, including pivotal CSRs (many with complex statistical plans), briefing documents, marketing application submission components, and responses to regulatory agency questions. In addition, as one of our senior reviewers, Rebecca has been praised for her willingness to take the time to teach and mentor her colleagues, ensuring they understand both the scientific and regulatory aspects of their projects.

Continue reading

Cheryl Ainslie, PhD, RAC, Promoted to Principal Clinical Research Scientist

RESEARCH TRIANGLE PARK, NC: 23 September 2020 – In March 2020, Cheryl Ainslie, PhD, RAC, was promoted to the position of Principal Clinical Research Scientist at Impact Pharmaceutical Services, Inc. (IMPACT).

Cheryl joined IMPACT in March 2018 and has been a positive and impactful member of our medical writing team since her first day. She has established herself as a strong and independent writer on various projects for small and large clients, and she continuously shows the highest level of professionalism. In addition to writing increasingly complex documents, Cheryl effectively managed an unpredictable safety reporting project, showing great flexibility, and effectively training and mentoring another writer on the project. As a senior reviewer, Cheryl has provided sound scientific feedback and guidance on a variety of projects, and she regularly receives praise on her ability to mentor and guide newer writers through project hurdles.

Continue reading

Ryan Overcash, PhD, Promoted to Principal Clinical Research Scientist

RESEARCH TRIANGLE PARK, NC: 23 September 2020 – In March 2020, Ryan Overcash, PhD, was promoted to the position of Principal Clinical Research Scientist at Impact Pharmaceutical Services, Inc. (IMPACT).

Ryan joined IMPACT in March of 2016 as a Clinical Research Scientist and started off managing a large narrative project and an IND safety reporting project; he then transitioned to managing a medical writing project for one of our clients. In addition to his project management roles, Ryan continues to actively write various regulatory documents, including IND modules, protocols, and CSRs, and he consistently develops excellent rapport with his teams. As one of our senior reviewers, he has taken some of our newer writers through their first protocol and CSR projects, receiving rave feedback on his ability to both mentor and review.

Continue reading

Elizabeth Pultorak, PhD, Promoted to Principal Clinical Research Scientist

RESEARCH TRIANGLE PARK, NC: 23 September 2020 – In March 2020, Elizabeth “Beth” Pultorak, PhD was promoted to the position of Principal Clinical Research Scientist at Impact Pharmaceutical Services, Inc. (IMPACT).

Continue reading